Trial Profile
A prospective randomized open label study Intranasal dexmedetomidine versus inhaled nitrous oxide for children age 3 – 15 years for procedural sedation and analgesia in pediatric emergency department.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Nitrous oxide
- Indications Sedation
- Focus Therapeutic Use
- 14 Jun 2017 New trial record